Blog

Feb 25, 2018

Harvard’s David Sinclair Treats Aging as a Disease and Plans to Launch a Clinical Trial to Prove It

Posted by in categories: biotech/medical, genetics, life extension

Harvard University’s David Sinclair, world renowned for his anti-aging research, sees no limit on human life span and is collaborating on a clinical trial to evaluate the effectiveness of a new drug aimed at slowing the aging process…

“There is no maximum human life span,” says Sinclair, Ph.D., who is a professor in the Department of Genetics and co-director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. “Anyone who says that doesn’t know what they are talking about.”

Sinclair hopes to demonstrate what he has been researching, – and talking about, for the past 20 years – that aging is a disease, which can be treated.

Read more

Comments are closed.